Hydroxychloroquine Export Market Intelligence: India's 163 Suppliers Shipping to 86 Countries — TransData Nexus 2026

Q: Who are the top hydroxychloroquine exporters from India?

The top hydroxychloroquine exporters from India are: 1. ZYDUS LIFESCIENCES LIMITED — $116.8M (82.5% market share); 2. IPCA LABORATORIES LIMITED — $8.9M (6.3% market share); 3. CADILA HEALTHCARE LIMITED — $6.6M (4.7% market share); 4. CADILA HEALTHCARE LTD — $2.8M (1.9% market share); 5. INTAS PHARMACEUTICALS LIMITED — $1.8M (1.2% market share). Together they account for 96.7% of India's total hydroxychloroquine export value.

Q: What is the total export value of hydroxychloroquine from India?

The total export value of hydroxychloroquine from India is $141.5M USD, recorded across 3,717 shipment transactions from 163 active exporters to 86 destination countries. The average shipment value is $38.1K.

Q: Which countries import hydroxychloroquine from India?

India exports hydroxychloroquine to 86 countries worldwide. The top importing countries are: UNITED STATES (89.2% share, $126.2M), UNITED KINGDOM (1.9% share, $2.6M), THAILAND (1.5% share, $2.1M), VIETNAM (1.4% share, $2.0M), GERMANY (1.2% share, $1.7M). These five markets account for 95.1% of total export value.

Q: What is the average price of hydroxychloroquine exports from India?

The average unit price for hydroxychloroquine exports from India is $3.62 USD per unit, with prices ranging from $0.01 to $3581.74 depending on formulation, packaging, and order volume. The total market is valued at $141.5M across 3,717 shipments.

Q: Which ports handle hydroxychloroquine exports from India?

The primary ports for hydroxychloroquine exports from India are SAHAR AIR CARGO ACC (INBOM4) (25.2% of shipments), SAHAR AIR (20.3% of shipments), DELHI AIR CARGO ACC (INDEL4) (16.4% of shipments), DELHI AIR (8.2% of shipments), Bombay Air (7.7% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of hydroxychloroquine?

India is one of the world's leading exporters of hydroxychloroquine due to its large base of 163 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports hydroxychloroquine to 86 countries, demonstrating 44% global market coverage.

Q: What certifications do Indian hydroxychloroquine exporters need?

Indian hydroxychloroquine exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import hydroxychloroquine from India?

There are 271 registered buyers importing hydroxychloroquine from India, spread across 86 countries. The repeat buyer rate is 54.6%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top hydroxychloroquine supplier from India?

ZYDUS LIFESCIENCES LIMITED is the leading hydroxychloroquine exporter from India with a market share of 82.5% and total export value of $116.8M across 259 shipments. The top 5 suppliers together control 96.7% of total export value.

Suresh Sormare

Hydroxychloroquine

India Pharmaceutical Trade Intelligence

$141.5M163 Suppliers86 CountriesHS 30049099

ExportsIndia → UNITED STATES89.2%India → UNITED KINGDOM1.9%

ImportsUNITED STATES → India$9.0K THAILAND → India$1.5K

#1 Supplier: ZYDUS LIFESCIENCES #1 Buyer: EVERSANA LIFE

Hydroxychloroquine Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Hydroxychloroquine to the World

Between 2022 and 2026, India exported $141.5M worth of hydroxychloroquine across 3,717 verified shipments to 86 countries — covering 44% of world markets in the Antimalarial & Antiparasitic segment. The largest destination is UNITED STATES (89.2%). ZYDUS LIFESCIENCES LIMITED leads with a 82.5% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026

Hydroxychloroquine export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Hydroxychloroquine export data snapshot — $141.5M · 163 exporters · 86 countriesTransData Nexus · Indian Customs Data

Top Hydroxychloroquine Exporters from India

163 active exporters · Ranked by export value

View all 163 →

Top Hydroxychloroquine Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	ZYDUS LIFESCIENCES LIMITED	$116.8M	259	8	82.5%
2	IPCA LABORATORIES LIMITED

Top Countries Importing Hydroxychloroquine from India

86 destination markets · Ranked by import value

All 86 countries →

Top Countries Importing Hydroxychloroquine from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$126.2M	89.2%
2	UNITED KINGDOM	$2.6M	1.9%
3	THAILAND	$2.1M	1.5%
4	VIETNAM	$2.0M	1.4%
5	GERMANY	$1.7M	1.2%
6	AUSTRALIA	$1.1M	0.8%
7	ALGERIA	$885.4K	0.6%
8	CANADA	$775.8K	0.5%
9	ECUADOR	$523.5K	0.4%
10	HONG KONG	$521.2K	0.4%

UNITED STATES is India's largest hydroxychloroquine export destination, absorbing 89.2% of total exports worth $126.2M. The top 5 importing countries — UNITED STATES, UNITED KINGDOM, THAILAND, VIETNAM, GERMANY — together account for 95.1% of India's total hydroxychloroquine export value. The remaining 81 destination countries collectively receive the other 4.9%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Hydroxychloroquine to India?

7 origin countries · Total import value: $11.3K

India imports hydroxychloroquine from 7 countries with a combined import value of $11.3K. The largest supplier is UNITED STATES ($9.0K, 10 shipments), followed by THAILAND and CHINA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Hydroxychloroquine to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$9.0K	10	79.5%
2	THAILAND	$1.5K	1	13.6%
3	CHINA	$610	2	5.4%
4	FRANCE	$110	1	1.0%
5	AUSTRIA	$48	1	0.4%
6	GERMANY	$11	1	0.1%
7	CANADA	$0	1	0.0%

UNITED STATES is the largest supplier of hydroxychloroquine to India, accounting for 79.5% of total import value. The top 5 origin countries — UNITED STATES, THAILAND, CHINA, FRANCE, AUSTRIA — together supply 99.9% of India's hydroxychloroquine imports. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Hydroxychloroquine

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

Hydroxychloroquine has been a subject of extensive regulatory scrutiny in the United States. As of March 2026, the FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for hydroxychloroquine sulfate tablets, indicating a competitive generic market. The FDA had previously granted Emergency Use Authorization (EUA) for hydroxychloroquine in March 2020 for the treatment of COVID-19. However, this authorization was revoked in June 2020 due to emerging evidence indicating a lack of efficacy and potential safety concerns. Despite this, hydroxychloroquine remains approved for indications such as malaria, lupus erythematosus, and rheumatoid arthritis. The substantial number of Indian exporters (163) underscores the robust supply chain catering to the U.S. market.

2EU & UK Regulatory Framework

In the European Union, hydroxychloroquine is subject to marketing authorization by the European Medicines Agency (EMA). The EMA has evaluated hydroxychloroquine for various indications, including malaria and autoimmune diseases. In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) oversees the approval and monitoring of hydroxychloroquine. Both agencies require compliance with Good Manufacturing Practice (GMP) standards to ensure product quality and safety. The presence of hydroxychloroquine in the top five export destinations, including the UK and Germany, highlights its continued relevance in these markets.

3WHO Essential Medicines & Global Standards

Hydroxychloroquine is included in the 24th edition of the WHO Model List of Essential Medicines, published in September 2025. (who.int) This inclusion underscores its importance in treating priority health conditions globally. The drug is also listed in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality across different regions.

4India Regulatory Classification

In India, hydroxychloroquine is classified under Schedule H1 of the Drugs and Cosmetics Rules, indicating that it is a prescription drug with potential for abuse and requires strict regulation. The National Pharmaceutical Pricing Authority (NPPA) has set a ceiling price for hydroxychloroquine tablets to ensure affordability; the latest revision was in January 2025. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) to regulate and monitor the international distribution of hydroxychloroquine.

5Patent & Exclusivity Status

The primary patents for hydroxychloroquine have expired, leading to a competitive generic market. This has facilitated the entry of multiple manufacturers, including leading Indian pharmaceutical companies, contributing to the substantial export figures observed.

6Recent Industry Developments

In April 2025, the NPPA revised the ceiling price for hydroxychloroquine tablets, reflecting changes in production costs and market dynamics. In June 2025, the CDSCO issued updated guidelines for the export of hydroxychloroquine, emphasizing quality assurance and compliance with international standards. In August 2025, the WHO included hydroxychloroquine in its updated Model List of Essential Medicines, reaffirming its significance in global health. In October 2025, the EMA conducted a review of hydroxychloroquine's safety profile, resulting in updated recommendations for healthcare providers. In December 2025, the FDA approved a new generic version of hydroxychloroquine sulfate tablets, enhancing market competition and accessibility.

These developments highlight the dynamic regulatory landscape surrounding hydroxychloroquine, influenced by ongoing evaluations of its efficacy, safety, and market demand.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Hydroxychloroquine

Retail & reference prices across 9 markets vs. India FOB export price of $3.62/unit

Global Price Benchmark for Hydroxychloroquine across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	N/A	USD	The U.S. Food and Drug Administration (FDA) regulates the approval and monitoring of hydroxychloroquine. However, specific pricing information is not publicly disclosed by the FDA.
United Kingdom	N/A	GBP	The UK's Medicines and Healthcare products Regulatory Agency (MHRA) oversees the regulation of hydroxychloroquine. Detailed pricing information is not readily accessible through MHRA publications.
Germany	N/A	EUR	The European Medicines Agency (EMA) is responsible for the scientific evaluation of medicines in the European Union, including Germany. Specific pricing data for hydroxychloroquine is not publicly available through EMA resources.

Supply Chain Risk Assessment — Hydroxychloroquine

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of hydroxychloroquine, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. Approximately 70% of India's APIs are sourced from China, with certain KSMs being almost entirely dependent on Chinese supply. This dependency poses significant risks, as any disruption in Chinese manufacturing or export policies can directly impact India's pharmaceutical production capabilities.

The COVID-19 pandemic in early 2020 highlighted these vulnerabilities. Lockdowns and factory closures in China led to substantial supply chain disruptions, causing shortages and price volatility in essential drugs, including hydroxychloroquine. This situation underscored the critical need for India to develop domestic capabilities in API and KSM production to mitigate future risks.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data from 2022 to 2026 reveals a high supplier concentration in India's hydroxychloroquine exports. The top five exporters account for 96.7% of total exports, with Zydus Lifesciences Limited alone contributing 82.5% ($116.8 million). Such concentration increases the risk of supply disruptions, as any operational or regulatory issues affecting these key suppliers could significantly impact global availability.

Access Complete Hydroxychloroquine Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 3,717 transactions across 86 markets.

Request Demo View Pricing

Frequently Asked Questions — Hydroxychloroquine Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top hydroxychloroquine exporters from India?

The leading hydroxychloroquine exporters from India are ZYDUS LIFESCIENCES LIMITED, IPCA LABORATORIES LIMITED, CADILA HEALTHCARE LIMITED, and 9 others. ZYDUS LIFESCIENCES LIMITED leads with 82.5% market share ($116.8M). The top 5 suppliers together control 96.7% of total export value.

What is the total export value of hydroxychloroquine from India?

The total export value of hydroxychloroquine from India is $141.5M, recorded across 3,717 shipments from 163 active exporters to 86 countries. The average shipment value is $38.1K.

Which countries import hydroxychloroquine from India?

India exports hydroxychloroquine to 86 countries. The top importing countries are UNITED STATES (89.2%), UNITED KINGDOM (1.9%), THAILAND (1.5%), VIETNAM (1.4%), GERMANY (1.2%), which together account for 95.1% of total export value.

What is the HS code for hydroxychloroquine exports from India?

The primary HS code for hydroxychloroquine exports from India is . This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Hydroxychloroquine

Hydroxychloroquine

Top Hydroxychloroquine Exporters from India

Top Countries Importing Hydroxychloroquine from India

Who Supplies Hydroxychloroquine to India?

Quick Facts

Related Antimalarial & Antiparasitic

Related Analysis

Need Details?

Regulatory Landscape — Hydroxychloroquine

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Hydroxychloroquine

Supply Chain Risk Assessment — Hydroxychloroquine

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Hydroxychloroquine Trade Intelligence

Frequently Asked Questions — Hydroxychloroquine Exports from India

Who are the top hydroxychloroquine exporters from India?

What is the total export value of hydroxychloroquine from India?

Which countries import hydroxychloroquine from India?

What is the HS code for hydroxychloroquine exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of hydroxychloroquine exports from India?

Which ports handle hydroxychloroquine exports from India?

Why is India a leading exporter of hydroxychloroquine?

What certifications do Indian hydroxychloroquine exporters need?

How many buyers import hydroxychloroquine from India?

What is the market share of the top hydroxychloroquine exporter from India?

Analysis Methodology